Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's disease itself -- as well as its symptoms -- in mice.
In experiments performed with cultures of human Brain Cells and live mouse models, they report the drug blocked the degradation of brain cells that is the hallmark of Parkinson's disease.
The drug is expected to move to clinical trials this year.